SYK expression in monomorphic epitheliotropic intestinal T-cell lymphoma

Area of Science:

• Gastroenterology
• Oncology
• Immunology

Background:

• Monomorphic epitheliotropic intestinal T-cell lymphoma (MEITL) is a rare, aggressive intestinal T-cell lymphoma with poor prognosis.
• Its pathogenesis remains incompletely understood, necessitating further investigation into its molecular characteristics.

Purpose of the Study:

• To comparatively investigate T-cell receptor (TCR) and associated signaling molecules in MEITL versus EATL.
• To elucidate the molecular mechanisms underlying MEITL pathogenesis, focusing on SYK and its regulatory pathways.

Main Methods:

• Comparative analysis of 40 MEITL and 27 EATL cases.
• Utilized immunohistochemistry, amplicon deep sequencing, and bisulfite pyrosequencing.
• Investigated TCR origin, SYK expression, promoter methylation, and mutations in DNMT3A, IDH2, and TET2.

Main Results:

• MEITL exhibits a predominant positive TCR phenotype (αβ and γδ) compared to EATL's silent phenotype.
• Spleen tyrosine kinase (SYK) overexpression (95%) is a distinctive feature of MEITL, linked to SYK promoter hypomethylation.
• Mutations in DNMT3A, IDH2, and TET2 were infrequent; LAT expression subdivided MEITL, suggesting potential differences in disease onset.

Conclusions:

• Aberrant SYK overexpression due to promoter hypomethylation is a key feature of MEITL, differentiating it from EATL.
• TCR phenotype and LAT expression provide further insights into MEITL heterogeneity and potential disease progression.
• Findings offer novel targets for understanding and potentially treating MEITL.